GlassScriptPhysician profile
Elizabeth Henson
NPI 1467164764
$965.52
in general payments reported to CMS, 2019-2025
17 companies · $705 in 2025
The $705 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $260 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $252.92 | 2025 | Austedo Xr, Ajovy |
| Neurelis, INC. | $124.74 | 2025 | Valtoco |
| Eisai INC. | $121.83 | 2025 | |
| Ucb, INC. | $114.54 | 2024-2025 | Briviact, Rystiggo, Nayzilam |
| Lundbeck LLC | $57.80 | 2024 | Rexulti, Vyepti |
| Corcept Therapeutics | $50.02 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $34.67 | 2025 | Hyqvia |
| Sk Life Science, INC. | $31.29 | 2024 | |
| Ani Pharmaceuticals, INC. | $26.67 | 2025 | Purified Cortrophin Gel |
| Acadia Pharmaceuticals INC | $25.52 | 2024 | Nuplazid |
| Abbvie INC. | $23.55 | 2025 | |
| Amneal Pharmaceuticals LLC | $20.46 | 2024 | Ongentys |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.62 | 2025 | Lifevest |
| Hospira, INC. | $16.97 | 2024 | |
| Merz Pharmaceuticals, LLC | $15.29 | 2024 | Xeomin |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.84 | 2024 | Emgality |
| Acorda Therapeutics, INC | $14.79 | 2024 | Inbrija |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Henson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.